Hemas Pharmaceuticals certified by Bureau Veritas


Hemas Pharmaceuticals, which has long been in the forefront of ensuring that the people of the country have access to the highest quality products, has now been recognised by Bureau Veritas as a Good Distribution Practices (GDP) organisation, marking yet another milestone.

GDP accreditation shows that Hemas Pharmaceuticals follows the World Health Organisation’s requirements for good distribution practices of pharmaceutical products. Furthermore, this accreditation assures that quality management systems are consistent throughout the supply chain. Bureau Veritas is a prominent certification body that supports organisations all over the world to enhance their performance.

Commenting on the recognition, Jude Fernando, Managing Director, Hemas Pharmaceuticals and Hemas Surgicals and Diagnostics stated: “I strongly believe that with this latest addition of accomplishment, we can aim to address the diverse and sophisticated needs of all our partners as every procedure follows international quality standards established for receiving, storing, and distributing pharmaceuticals. As the number one Sri Lankan pharmaceutical importer and distributor, now we are honoured to serve our principals with both the accolades of ISO 9001:2015 and GDP certification from Bureau Veritas, which is globally recognised and clearly demonstrates the Hemas Pharmaceuticals commitment on compliance and quality”.